Motley Fool Money cover image

Business Plans and Science Projects

Motley Fool Money

00:00

Evaluating Streaming Service Value and Advances in Regenerative Medicine

This chapter explores the benefits and drawbacks of ESPN's subscription services, especially in the context of college and NFL football. It also discusses Mesoblast, a cutting-edge company in regenerative medicine, and its FDA-approved therapy for pediatric patients facing bone marrow transplants.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app